{"8":{"dur":8,"text":">>Chrystia Freeland: Marc is holding now a\ngreat invention of his. And 1984 turns out"},"16":{"dur":5,"text":"to be an important year for this entire panel.\nThat's the year that Guy got his important"},"22":{"dur":4,"text":"not grant, but contract from the government\nof Canada. It's the year that Marc -- and"},"26":{"dur":5,"text":"correct me if I'm mistaken here -- read about\nhow syringes were being reused and that was"},"31":{"dur":6,"text":"spreading HIV. One of those heart-wrenching\nstories that we often read. But unlike most"},"38":{"dur":4,"text":"of us, when Marc read this, he decided to\nchange his life and do something about it."},"42":{"dur":4,"text":"And that's what he's been doing ever since,\nboth founding a company producing syringes"},"47":{"dur":6,"text":"which can't be reused, and also an NGO that\nspreads awareness of it."},"54":{"dur":4,"text":"Sitting next to him is Sipho Moyo. I'm so\nglad that Sipho is here, because so often"},"59":{"dur":5,"text":"I think a lot of our discussion is going to\nbe about Africa, and so often I moderate panels,"},"64":{"dur":5,"text":"especially at conferences like this, where\nWestern people talk a lot about the problems"},"70":{"dur":5,"text":"of Africa in very wise ways and nod our heads.\nSo it's good to have at least one actual African"},"76":{"dur":5,"text":"here. Sipho has 18 years of development experience\nin Africa. She has worked all over the continent,"},"82":{"dur":3,"text":"Tanzania, most recently Nigeria. She's in\nJohannesburg now."},"85":{"dur":6,"text":"She emphasized to me that she is not Dambisa\nMoyo, although she has some controversial"},"92":{"dur":6,"text":"and sharp views herself and her father did\nteach Dambisa and their friends."},"98":{"dur":1,"text":">>Sipho Moyo: Dambisa's father taught me.\n>>Chrystia Freeland: Dambisa's father taught"},"100":{"dur":6,"text":"her. So we have connections here.\nAnd then, of course, famous to everyone who"},"106":{"dur":2,"text":"lives in Britain, Dame Barbara Stocking. I\nfeel I should curtsey when --"},"108":{"dur":5,"text":">>Barbara Stocking: Could you stop saying\n\"dame\"? It doesn't sort of going with Oxfam"},"113":{"dur":4,"text":"somehow. Or just drop that one.\n>>Chrystia Freeland: Who is the CEO of Oxfam,"},"117":{"dur":6,"text":"Great Britain. This is one of the world's\nmost admired and accomplished philanthropies."},"124":{"dur":5,"text":"Four and a half thousand employees, a budget\nof three and a half million pounds, doing"},"129":{"dur":5,"text":"huge and really important work around the\nworld. And it's really important, making some"},"134":{"dur":5,"text":"really important connections that we'll talk\nabout, I hope, on this panel, about connecting"},"140":{"dur":5,"text":"the dots between what businesses do in their\nbusiness and how they can make the world a"},"145":{"dur":2,"text":"better place, a little bit what we've been\ntalking about with Guy."},"148":{"dur":3,"text":"How we're going to organize this panel is\nI'm going to ask our brilliant panelists questions"},"151":{"dur":6,"text":"for about 15 minutes. I hope they'll all jump\nin and very kindly but forcefully disagree"},"158":{"dur":7,"text":"with one another where they have reason to.\nThen we will have about 15 or 20 minutes for"},"166":{"dur":6,"text":"questions, and we will end promptly at 5:00,\nI promise you dear Zeitgeisters."},"172":{"dur":8,"text":"So starting with Marc, talk to us a little\nbit, Marc, about -- I mean, the idea seems"},"181":{"dur":9,"text":"so obvious that syringes which are reused\ncan spread disease. And yet, you have found"},"190":{"dur":7,"text":"it far from obvious and far from easy to actually\nhave these non-reusable syringes be the ones"},"197":{"dur":3,"text":"that are being used.\nSo why is it so hard? What are the obstacles?"},"201":{"dur":5,"text":">>Marc Koska: I wish I knew. When I started\nin 1984, I thought I'll come up with a design,"},"207":{"dur":3,"text":"two years later, I'll go traveling.\nBut it actually has --"},"210":{"dur":2,"text":">>Chrystia Freeland: Tell us -- describe the\ndesign briefly."},"213":{"dur":6,"text":">>Marc Koska: It's still a big problem. Basically,\nfor the audience, the -- a normal syringe"},"219":{"dur":5,"text":"can be reused because it's just a plastic\nbarrel with a plunger in it. What I designed"},"225":{"dur":5,"text":"after three years of research is this product.\nIt looks like a normal syringe. And after"},"230":{"dur":6,"text":"use, in the patient, it's discarded. If someone\nthen tries to pick it up and refill it, the"},"237":{"dur":4,"text":"action of pulling back the plunger makes it\nlock and break, and it can't be used again."},"242":{"dur":7,"text":"And the key to this was that it's made on\nexisting equipment in the manufacturing systems"},"249":{"dur":2,"text":"that exist. There are about 600 factories\nin the world."},"251":{"dur":4,"text":"So what I wanted to do was come up with a\ndesign which didn't force any change or extra"},"256":{"dur":7,"text":"cost to manufacturers, can be used in the\nsame way, and costs exactly the same as a"},"263":{"dur":1,"text":"normal syringe.\nThank you."},"265":{"dur":5,"text":">>Chrystia Freeland: Now, if you doubt the\nimportance of that syringes, I urge you during"},"271":{"dur":6,"text":"the breaks to accost Marc and ask him to play\nyou a video on his phone -- I'm afraid it's"},"277":{"dur":7,"text":"not an Android; it's actually an iPhone -- of\nsome scenes that you've taken -- some covert"},"284":{"dur":5,"text":"scenes you've taken inside clinics.\n>>Marc Koska: It's still going on, today,"},"290":{"dur":5,"text":"something like 60% of all injections in India\nare unsafe. The same system -- or the same"},"295":{"dur":5,"text":"numbers are apparent in most developing world\ncountries. And it's not really clear, there's"},"300":{"dur":2,"text":"not one particular reason.\n>>Chrystia Freeland: People going in to get"},"303":{"dur":4,"text":"immunizations for their babies?\n>>Marc Koska: Immunizations are not too bad"},"307":{"dur":5,"text":"if they're U.N. run or NGO run, because there's\na mandate for immunizations to be given with"},"313":{"dur":6,"text":"these safe syringes. Those represent only\na small percentage. The vast majority of injections"},"319":{"dur":8,"text":"are not in any way safe if they don't use\nthis or they don't use correct procedure."},"327":{"dur":4,"text":"So we end up with something like 1.3 million\ndeaths -- World Health Organization number"},"331":{"dur":6,"text":"-- being caused every single year, which is\ntwice the amount of the death toll of malaria"},"338":{"dur":5,"text":"even. And what angers me is, this is caused\nby a doctor or a nurse. This isn't, you know,"},"344":{"dur":6,"text":"an innocent mosquito. This is actually being\ntransmitted to the patients via a health care"},"350":{"dur":3,"text":"worker.\n>>Chrystia Freeland: Do you find government"},"354":{"dur":3,"text":"bureaucracies an obstacle?\n>>Marc Koska: Yes."},"358":{"dur":5,"text":">>Chrystia Freeland: How and why?\n>>Marc Koska: There's a lot of corruption."},"363":{"dur":3,"text":"There's a lot of bribery. You know, there\nare more -- at the moment, there are more"},"367":{"dur":4,"text":"normal syringe manufacturers in the world\nthan there are safety syringe manufacturers"},"372":{"dur":5,"text":"in the world. And they seem to win. I don't\nknow how it works out, but they seem to keep"},"377":{"dur":6,"text":"the status quo going where they're supplying,\nyou know, sometimes unsterile products, but"},"383":{"dur":6,"text":"they're in a package. They look sterile. And\nthey're coming in at very, very underpriced"},"390":{"dur":3,"text":"levels, so they're just flooding the market\nwith these products."},"393":{"dur":4,"text":"It is particularly dangerous, because syringes\nare the most commonly used piece of medical"},"398":{"dur":5,"text":"equipment in the world. So if you've got a\nbase where disease is being spread from the"},"403":{"dur":5,"text":"actual most commonly used medical product\nin the world, that's pretty perverse."},"408":{"dur":7,"text":">>Chrystia Freeland: Now, Marc, if I were\nan African health minister and you came to"},"415":{"dur":5,"text":"sing the virtues of your syringe, I might\nsay to you, but, come on, you're selling me"},"420":{"dur":3,"text":"this stuff. Aren't you just trying to make\nlots of money?"},"424":{"dur":3,"text":"So what's your come-back?\n>>Marc Koska: Well, that is obviously true."},"428":{"dur":5,"text":"I do run a company, and we license these to\n13 manufacturers now around the world and"},"433":{"dur":2,"text":"make a couple of million of these units a\nday."},"435":{"dur":8,"text":"But it is absolutely true. And I think whether\nI directly profit or not, I'm not really -- don't"},"444":{"dur":4,"text":"really have time to defend. What I want to\ndo is change the scene quite dramatically."},"448":{"dur":7,"text":"I want to see if I can put into action an\nidea that I've got where we open-source good"},"455":{"dur":5,"text":"ideas, where good ideas are no longer constrained\nunder commercial reality."},"460":{"dur":4,"text":"And to the audience, you'll think I'm mad,\nbecause, obviously, you live in the commercial"},"465":{"dur":3,"text":"world where it's dog eat dog and every margin\ncounts. But, actually --"},"469":{"dur":3,"text":">>Chrystia Freeland: They're muzzled. It's\na conference. They're not fighting."},"472":{"dur":4,"text":">>Marc Koska: What I might profit out of this\nproduct does not matter. What matters is that"},"477":{"dur":6,"text":"this reaches its humanitarian scale and it\ndoes its job and we eradicate that 1.3 million."},"483":{"dur":4,"text":">>Chrystia Freeland: Marc, I think you're\ntrying to think about ways to get around this"},"488":{"dur":4,"text":"potential conflict, where you're selling a\nsolution, but you also run a company that"},"493":{"dur":2,"text":"wants to make money. How can you square that\ncircle?"},"495":{"dur":5,"text":">>Marc Koska: Well, the idea that I'm working\non at the moment is that we kind of eradicate"},"500":{"dur":2,"text":"the company angle and we try and transfer\n--"},"503":{"dur":4,"text":">>Chrystia Freeland: Shut down your company?\n>>Marc Koska: Shut down the company selectively,"},"507":{"dur":4,"text":"and I use that word very advisedly. Because\nthis isn't a launch of the idea. This is just"},"512":{"dur":6,"text":"a conceptual description of the idea. The\nidea would be that we somehow shut down the"},"518":{"dur":6,"text":"company and we pass over the designs to an\nopen sourcing system where we --"},"525":{"dur":2,"text":">>Chrystia Freeland: Going to go Google?\n>>Marc Koska: We go Google, we allow everyone"},"528":{"dur":5,"text":"to manufacture the product. And as long as\nthey meet constraints of quality and targets"},"533":{"dur":7,"text":"of production, that, you know, somehow we\nreward them with an open source type royalty"},"540":{"dur":2,"text":"rebate or something along those lines.\n>>Chrystia Freeland: How will that make you"},"543":{"dur":2,"text":"more effective, you do think?\n>>Marc Koska: Well, I think it takes away,"},"546":{"dur":4,"text":"one, the elephant in the room, the one that\nyou mentioned, of, \"Is he making money out"},"551":{"dur":5,"text":"of it?\" But also it allows me to be much more\nvocal and hold a gun to these ministers' heads."},"556":{"dur":1,"text":">>Chrystia Freeland: Hold guns to the ministers'\nheads?"},"558":{"dur":3,"text":">>Marc Koska: I'm going to say, \"Change, or\nyou're part of the problem.\""},"561":{"dur":7,"text":">>Chrystia Freeland: How -- you have to live.\nSo how can you take the financial element"},"568":{"dur":4,"text":"out of the equation? Do you need a sugar daddy\nto come in?"},"573":{"dur":3,"text":">>Marc Koska: Yeah, yeah. We're looking at\nexactly that. And sugar daddies, let's face"},"576":{"dur":6,"text":"it, normally set up funds. And their ultimate\nreward is to save a life or to improve a life."},"582":{"dur":4,"text":"And if -- you know, if the dialogue goes along,\nlook, if you gave me \"X\" million dollars and"},"587":{"dur":5,"text":"I could save \"X\" million lives, would you\nbe willing to do it? I think there are plenty"},"592":{"dur":3,"text":"out there that want that.\nI think it only works with certain products."},"596":{"dur":5,"text":"They've got to be pretty well developed. They've\ngot to have proven that they deserve a place"},"601":{"dur":7,"text":"in the world and that they can be scaled and\nbe just as effective scaled without any detriment."},"609":{"dur":5,"text":"And I feel this is a no-brainer, because we've\ngot a market already out there. We've got"},"614":{"dur":5,"text":"a manufacturing system out there already,\nand they are just making almost this product"},"619":{"dur":1,"text":"but not quite. And the changeover is pretty\neasy."}}